A Vertebrate Homolog of the Cell Cycle Regulator Dbf4 Is an Inhibitor of Wnt Signaling Required for Heart Development  by Brott, Barbara K. & Sokol, Sergei Y.
Developmental Cell, Vol. 8, 703–715, May, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.devcel.2005.02.012
A Vertebrate Homolog of the Cell Cycle
Regulator Dbf4 Is an Inhibitor of Wnt Signaling
Required for Heart Development
Barbara K. Brott1 and Sergei Y. Sokol1,2,*
1Department of Microbiology and Molecular Genetics
Harvard Medical School and
Department of Medicine




Early stages of vertebrate heart development have
been linked to Wnt signaling. Here we show in both
gain- and loss-of-function experiments that XDbf4, a
known regulator of Cdc7 kinase, is an inhibitor of the
canonical Wnt signaling pathway. Depletion of endog-
enous XDbf4 protein did not disturb gastrulation
movements or early organizer genes but resulted in
embryos with morphologically defective heart and
eyes and suppressed cardiac markers. These mark-
ers were restored by overexpressed XDbf4, or an
XDbf4 mutant that inhibits Wnt signaling but lacks the
ability to regulate Cdc7. This indicates that the func-
tion of XDbf4 in heart development is independent of
its role in the cell cycle. Moreover, our data suggest
that XDbf4 acts through the physical and functional
interaction with Frodo, a context-dependent regulator
of Wnt signaling. These findings establish an unex-
pected function for a vertebrate Dbf4 homolog and
demonstrate the requirement for Wnt inhibition in
early cardiac specification.
Introduction
The induction and morphogenesis of the vertebrate
heart is a complex process involving multiple interac-
tions between all three germ layers and precise tempo-
ral-spatial patterning (Fishman and Chien, 1997; Jacob-
son, 1960). In Xenopus embryos, heart induction begins
during gastrulation, when factors from the Spemann or-
ganizer (a dorsal signaling center [Harland and Gerhart,
1997]) and the dorsoanterior endoderm interact with
adjacent mesoderm to specify bilateral heart fields
(Fishman and Chien, 1997; Olson and Schneider, 2003;
Stainier, 2001). By neurulation, the genes Nkx2.5, Tbx5,
and GATA-4 implicated in heart field specification
(Grow and Krieg, 1998; Horb and Thomsen, 1999; Jiang
and Evans, 1996; Patterson et al., 1998) can be de-
tected in presumptive cardiac regions (Chen and Fish-
man, 1996; Kelley et al., 1993). At tail bud stages, the
two heart primordia migrate to fuse into a single heart
tube. Disruption of this process in vertebrates has been
shown to cause cardia bifida (Chen et al., 1996; Glick-
man and Yelon, 2002; Komada and Soriano, 1999; Saga*Correspondence: sergei.sokol@mssm.edu
2Present address: Department of Molecular, Cell, and Develop-
mental Biology, Mount Sinai School of Medicine, One Gustave Levy
Place, Box 1020, New York, New York 10029.et al., 1999; Walters et al., 2001; Yelon, 2001). At this
time, structural genes such as cardiac troponin Ic (TnIc)
and myosin heavy chain α (MHCa) begin to be ex-
pressed (Drysdale et al., 1994; Logan and Mohun,
1993). At later stages, the heart tube undergoes looping
and segmentation, and the valves form. Finally, cardio-
myocytes undergo high levels of proliferation as the
tube transforms into the three-chambered heart (Pasu-
marthi and Field, 2002).
Wnt signaling is among the molecular pathways that
lead to heart development. In the canonical pathway,
secreted Wnt ligands act via Dishevelled (Dsh/Dvl) to
stabilize β-catenin and allow its interaction with the T
cell factor (TCF) family of transcription factors, resulting
in transcription of Wnt-responsive genes (Nusse, 1999;
Sokol, 1999; van Es et al., 2003). Signaling by different
Wnt family members contributes both positively and
negatively to cardiogenesis. On one hand, Wnt11 has
been shown to initiate heart development through path-
ways involving protein kinase C and c-Jun N-terminal
kinase (Pandur et al., 2002). On the other hand, the Wnt
antagonists Dkk1 and Crescent (Glinka et al., 1998;
Pera and De Robertis, 2000) are able to induce Nkx2.5
and other heart-specific markers upon ectopic expres-
sion in Xenopus and chick embryos (Marvin et al., 2001;
Schneider and Mercola, 2001; Tzahor and Lassar,
2001). These findings led to a model in which Wnt inhib-
itors secreted by the organizer into adjacent tissues
contribute to heart field specification. Consistent with
this hypothesis, downregulation of Wnt signaling by
targeted disruption of β-catenin in the murine definitive
endoderm leads to induction of multiple hearts (Lickert
et al., 2002). Additionally, zebrafish embryos with trun-
cated adenomatous polyposis coli (APC), a β-catenin
antagonist, exhibit defects in endocardial differentia-
tion and heart valve formation (Hurlstone et al., 2003).
Despite this evidence, no loss-of-function studies have
uncovered a role for Wnt inhibition in early cardiac
specification.
Here we show in gain- and loss-of-function experi-
ments that XDbf4, a Xenopus homolog of yeast Dumb-
bell former 4 (Jackson et al., 1993), inhibits Wnt signal-
ing and is crucial for heart development. XDbf4 may
downregulate Wnt pathways through physical and
functional interactions with Frodo (Cheyette et al.,
2002; Gloy et al., 2002; Hikasa and Sokol, 2004), a re-
cently described component of canonical Wnt signal-
ing. This function contrasts with the previously estab-
lished role for Dbf4 homologs in cell cycle regulation
(Furukohri et al., 2003; Kumagai et al., 1999). Finally, our
study demonstrates that a Wnt inhibitor is required for
early cardiogenesis.
Results
XDbf4 Is a Frodo Binding Protein that Is Expressed
in Xenopus Early Development
In a yeast two-hybrid screen for proteins interacting
with Frodo, we identified XDbf4 (Furukohri et al., 2003),
Developmental Cell
704a homolog of yeast Dbf4 (Jackson et al., 1993) and s
imammalian activator of S phase kinase (Kumagai et al.,
1999). These proteins share three conserved sequence a
smotifs (N, M, and C, Figure 1A). In yeast, the M and C
motifs of Dbf4 are required for the binding and activa- b
ation of the cell cycle kinase Cdc7 (Masai and Arai, 2000;
Ogino et al., 2001). To establish whether XDbf4 associ- s
(ates with Frodo in Xenopus embryos, we carried out
immunoprecipitation analysis with embryonic lysates t
(containing tagged proteins. Both wild-type XDbf4 and
XDbf4-MC, a mutated construct lacking the M and C s
edomains (Figure 1A), were found in Frodo-containing
immune complexes but not in control immunoprecipi- h
ftates (Figure 1B). These results demonstrate that XDbf4
associates with Frodo in embryonic cells and that this w
cinteraction does not require the Cdc7 binding domains
of XDbf4. X
2If XDbf4 and Frodo interact in the embryo, their ex-
pression patterns should overlap at some develop- F
mental stages. In situ hybridization for XDbf4mRNA ex-
pression in embryos revealed that at blastula and X
Tgastrula stages XDbf4 is expressed predominantly in
the animal hemisphere, most strongly on the dorsal sFigure 1. XDbf4 Associates with Frodo and Is Expressed throughout Xenopus Development
(A) Diagram of XDbf4 and XDbf4-MC with amino acid numbers indicated. Domains N, M, and C conserved between XDbf4 and yeast Dbf4
are shown.
(B) XDbf4 and XDbf4-MC coimmunoprecipitate with Frodo. Lysates of embryos injected with Myc-tagged XDbf4 or XDbf4-MC (MC) and
HA-tagged FrdB mRNA were precipitated with anti-HA antibody as indicated. Top panel, Myc-XDbf4 and Myc-MC coprecipitated with FrdB
was detected with anti-Myc antibodies; middle panel, precipitated HA-FrdB detected with anti-HA antibodies; bottom panel, Myc-XDbf4 and
Myc-MC detected with anti-Myc antibodies in whole lysates. C, uninjected control embryos.
(C–N) In situ hybridization analysis of XDbf4 expression. (C–G, I, and J) XDbf4 antisense probe. (H and K) Chordin antisense probe as a
specificity control. (C) Stage 9, animal pole view. (D) Stage 9, lateral view. (E) Stage 10.5, gastrula, dorsal view. (F) Stage 20, late neurula,
dorsal view. (G) Stage 22, lateral view. (H) Stage 10, vegetal view. (E and H) Arrowheads point to dorsal lip. (I and K) Stage 26. (J) Stage 35/
36. (F, G, and I–K) Anterior is to the left. (L, M, and N) Sections from the regions indicated in (I) and (K); dorsal is up. ha, heart anlage; e, eye
vesicle; en, endodermal yolk mass; sa, stomodeal anlage; ms, mesencephalon; fg, foregut; nc, notochord. Bar in L, 200 m, also corresponds
to M and N.
(O) Developmental expression of XDbf4 protein. Western analysis of embryo lysates with anti-XDbf4 antibodies was carried out at indicated
stages. A vertical bar indicates multiple phosphorylation states of XDbf4; asterisk, a nonspecific protein band reflects loading; M.W., molecular
weight markers.ide (Figures 1C–1E). During neurulation, XDbf4 mRNA
s detected predominantly in the neural plate (Figure 1F)
nd enriched in the optic vesicle (Figure 1G). At later
tages the staining appears mainly in the developing
rain, heart anlagen, developing eyes, and branchial
rches (Figures 1I, 1J, 1L, and 1M), as confirmed by
ections of stage 26 whole mount stained embryos
Figures 1L–1N). This pattern of expression is similar
o that of Frodo and the Frodo-related gene Dapper
Cheyette et al., 2002; Gloy et al., 2002). A control anti-
ense probe to chordin exhibited different patterns of
xpression (Figures 1H, 1K, and 1N). Western analysis
as shown the presence of the XDbf4 protein at dif-
erent developmental stages (Figure 1O). Several bands
ith the apparent MW of 89–110 kDa were detected,
onsistent with varying levels of phosphorylation of
Dbf4 observed in Xenopus oocytes (Furukohri et al.,
003). Together, these results show that XDbf4 and
rodo are coexpressed in the same embryonic regions.
Dbf4 Is a Negative Regulator of Wnt Signaling
he biochemical interaction between XDbf4 and Frodo
uggested a role for XDbf4 in Wnt signaling. To investi-
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705gate this possibility we examined the ability of XDbf4
to affect primary axis formation in developing embryos.
Dorsal-marginal expression of both wild-type and the
XDbf4-MC mutant resulted in embryos with deficient
head and eye development (Figures 2A and 2B). Reduc-
tion of anterior structures is similar to the phenotype of
embryos rendered ventralized by ultraviolet irradiation
(Harland and Gerhart, 1997), supporting the possibility
that XDbf4 may downregulate Wnt signaling during
early axis specification. We then examined whether
XDbf4 regulates secondary axis induction and tran-
scriptional reporter activation in response to Wnt sig-
naling. XDbf4 blocked β-catenin- or Dsh-induced sec-
ondary axes in mRNA coinjection experiments (Figure
2C). Furthermore, both XDbf4 and XDbf4-MC effi-
ciently suppressed β-catenin-mediated activation of
pSiaLuc, a Wnt-responsive transcriptional reporter
(Brannon et al., 1997; Fan et al., 1998) (Figure 2D). The
ability of XDbf4-MC to repress reporter activity indi-
cates that the M and C motifs are not essential for Wnt
inhibition. XDbf4 also suppressed secondary axes in-
duced by TCF-VP16, an activated form of TCF (VonicaFigure 2. XDbf4 Inhibits Canonical Wnt Signaling
(A and B) Ventralization of embryos expressing XDbf4 and the MC mutant. XDbf4, MC, or the control GFP mRNA (3 ng each) was injected
into two dorsal blastomeres of four-cell embryos. (A) Representative embryos. (B) Dorsoanterior indices (DAI) were determined at stage 37
as described (Kao and Elinson, 1988).
(C) The effect of XDbf4 on secondary axis induction by Dsh and β-catenin. XDbf4 mRNA (3 ng) or a control mRNA (3 ng) was coinjected with
Dsh (50 pg) or β-catenin (25 pg) mRNA into two ventral-vegetal blastomeres.
(D) XDbf4 and MC downregulate a Wnt-responsive promoter. XDbf4 or MC mRNA (3 ng) was injected into two ventral-animal blastomeres
along with pSia-Luc DNA (20 pg) and β-catenin mRNA (25 pg). RLU, relative light units. Means ± standard deviations are shown for triplicate
samples.
(E–H) XDbf4 mRNA (3 ng or as indicated) was coinjected into two ventral-vegetal blastomeres with TCF-VP16 RNA (TCFVP, 2 pg or as
indicated, [E] and [F]), or Xnr1 RNA (5 pg, [G] and [H]). Embryos were scored for complete (black shading) or partial (light shading) secondary
axes at stages 36–38. Complete axes are defined by the presence of a second head with eyes and a cement gland; partial axes are composed
of a secondary trunk without anterior head structures.et al., 2000) (Figures 2E and 2F), although not as effi-
ciently as for β-catenin or Dsh. This effect was specific
to the Wnt pathway, since XDbf4 did not inhibit partial
secondary axes induced by Xenopus Nodal-related 1
(Xnr1, Jones et al., 1995), which functions in a Wnt-
independent manner (Figures 2G and 2H). Together, our
data show that XDbf4 acts as a specific inhibitor of
Wnt signaling.
XDbf4 Depletion Activates Wnt Signal Transduction
To further investigate the role of XDbf4 in Wnt signaling
and development, antisense morpholino oligonucleo-
tides were designed to inhibit XDbf4 expression. The
XDbf4 morpholino 1 (XDMO1) inhibited in vitro transla-
tion of XDbf4 mRNA in rabbit reticulocyte lysates but
did not inhibit translation of Myc-XDbf4 mRNA lacking
the target sequence (Figure 3A). Moreover, XDMO1 and
a second morpholino, XDMO2, but not a control mor-
pholino (CMO), significantly depleted endogenous
XDbf4 protein when injected into Xenopus embryos
(Figure 3B). Coinjection of both morpholinos caused an
even further reduction of XDbf4 levels (Figure 3B). We
Developmental Cell
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(A) XDbf4 morpholino (XDMO1) inhibits in vitro translation of XDbf4 mRNA, but not Myc-XDbf4 mRNA that lacks the target sequence. A
control morpholino (CMO) did not have this effect.
(B) XDMO1 (6 pmol), XDMO2 (1 pmol), or a control morpholino (6 pmol) was injected into all four blastomeres of Xenopus embryos as
indicated. Lysates of stage 20 embryos were subjected to Western analysis with anti-XDbf4 antibody. XDbf4 is depleted, whereas a nonspe-
cific control protein (*) was not altered in XDbf4-depleted embryos.
(C) XDMO1 upregulates the response of TOPflash, but not FOPflash, to β-catenin mRNA. Two ventral-animal injections of XDMO1 (6 pmol)
were followed by coinjection of β-catenin mRNA (25 pg) and TOPflash or FOPflash DNA (30 pg). Means ± standard deviations are shown for
triplicate samples.
(D) XDMO1 upregulates the response of pSia-Luc to TCF-VP16. Two ventral-animal injections of XDMO1 (6 pmol) were followed by coinjection
of pSia-Luc DNA (20 pg) and TCF-VP16 mRNA (TCFVP, 2 pg).
(E) The stimulatory effect of XDMO1 is suppressed by XDbf4 and DMC mRNAs. XDMO1, β-catenin RNA, and pSia-Luc were injected into
embryos as indicated, with or without XDbf4 or DMC mRNA (3 ng each).next evaluated the effects of XDMO1 on Wnt-depen- p
fdent transcriptional responses and observed that it
upregulated both β-catenin- and TCF-VP16-dependent w
oactivation of the pSiaLuc and TOP-Flash (Korinek et al.,
1998) reporters (Figures 3C and 3D). When XDbf4 or u
XDMC mRNA, each lacking the morpholino target se-
quence, was coinjected with β-catenin mRNA following A
fXDMO1 injection, this elevation of Wnt signaling was
suppressed (Figure 3E), indicating that the effect of a
tXDMO1 is highly specific. Together with our gain-of-
function studies, these findings demonstrate that f
XXDbf4 acts at the level of TCF to inhibit canonical Wnt
signaling. e
(
eXDbf4 Depletion in Dorsal and Dorsolateral cMesoderm Results in Heart and Eye Defects a
To assess a developmental role for XDbf4, we exam- i
ined the phenotype of XDbf4-depleted embryos. Em- p
bryos injected dorsally with XDMO1 did not reveal any (
morphological abnormalities during gastrulation and r
neurulation. Blastopore closed normally in XDMO1-
injected embryos (n > 50), when compared with em-
bryos injected with the same dose of CMO. By stage X
S43, embryos injected with either XDMO1 or XDMO2 had
small or undetectable hearts, whereas beating hearts M
Twere clearly visible in wild-type embryos and embryos
injected with three different control morpholinos (Fig- l
eures 4A and 4B). In addition, XDbf4-depleted tadpoles
exhibited mild edema and small eyes with an enlargederiocular region. Tissue sections revealed cardia bi-
ida in one-third of XDbf4-depleted embryos (n = 9),
hile the remaining embryos had grossly underdevel-
ped hearts with at most two chambers present (Fig-
res 4C and 4D). These observations indicate that
Dbf4 is required for both heart and eye development.
s heart induction involves interactions between dif-
erent germ layers (Fishman and Chien, 1997; Olson
nd Schneider, 2003; Stainier, 2001), we wanted to de-
ermine which tissue requires the presence of XDbf4
or cardiogenesis. 32-cell embryos were injected with
DMO1 into tier D blastomeres to target presumptive
ndoderm or tier C to target prospective mesoderm
Figure 4E; Dale and Slack, 1987; Moody, 1987). Lin-
age tracing and subsequent sectioning of embryos
onfirmed the predicted tissue contribution (Figures 4F
nd 4G), and showed that embryos depleted of XDbf4
n mesoderm exhibited stronger heart defects as com-
ared with embryos depleted of XDbf4 in endoderm
Figures 4G and 4H). We conclude that XDbf4 is mainly
equired for heart specification in mesoderm.
Dbf4-Depleted Embryos Are Deficient in Heart
pecification but Exhibit No Defects in Early
orphogenesis or Dorsoventral Patterning
o examine the molecular basis for observed morpho-
ogical defects in heart development in XDbf4-depleted
mbryos, we examined early genes of dorsoventral andanteroposterior patterning as well as cardiac-specific
XDbf4, a Wnt Inhibitor in Heart Development
707Figure 4. XDbf4 Is Necessary for Heart and Eye Development
(A and B) Embryos were injected twice into the dorsal margin with morpholinos as indicated at the following doses: XDMO1 (6 pmol), XDMO2
(1 pmol), or control morpholinos, CMO, CMO2, CMO3 (6 pmol each). Heart and eye phenotypes were assessed at stage 43. (A) Representative
embryos. (B) Quantitation of phenotypes. Heart defects were scored at stage 43 as follows. 0, no visible heart tissue; 1, severe defects in
heart formation; 2, small heart without circulating blood; 3, small heart with circulating blood; 4, wild-type heart. For eye defects (stage 43):
0, no visible eye; 1, severely disrupted retina with little pigmentation; 2, microphthalmia with pigmentation defects; 3, small pigmented eye;
4, wild-type eye. (C and D) Depletion of XDbf4 results in cardia bifida or small hearts.
(C) Representative hematoxylin/eosin-stained cross-sections of embryos injected as in (A).
(D) Sections of injected embryos stained with anti-muscle actin antibodies as whole mounts. Bar in left panel, also refers to (D) and (G), is
200 m. (C) Left two panels, stage 37; right two panels, stage 40. (D) Stage 37. Arrowheads indicate heart tissue.
(E) Scheme for assessing the role of XDbf4 in different germ layers. XDMO1 (6 pmol) was coinjected with LacZ RNA (100 pg) as a lineage
tracer into four dorsal-vegetal (dv, tier D) or four dorsal-marginal (dm, tier C) blastomeres of 32-cell stage embryos. An, animal; Veg, vegetal;
Do, dorsal, Ve, ventral.
(F) Lineage tracing was carried out in stage 36–38 embryos by staining with RedGal (indicated by arrowheads in [F] and by asterisks in [G]).
(G) Methyl Green-stained sections show normal heart morphology in a tier D-injected embryo (left panel, endoderm cells labeled) and a small
heart in a tier C-injected embryo (right panel, head mesenchyme labeled). Arrowhead indicates the heart tissue. ov, otic vesicle; hm, head
mesenchyme; fg, foregut; nc, notochord; bv, brain ventricle.
(H) XDbf4 is required in the dorsal and dorso-lateral mesoderm for heart development. Data representative of three different experiments are
shown. Heart defects were scored as in (B). Means and standard deviations are presented; asterisk, statistically different from ** (p < 0.01).markers by in situ hybridization and RT-PCR. Stage
10.5 embryos coinjected dorsally with XDMO1 and
XDMO2 were analyzed for expression of the organizer
markers Chordin (Chd), Goosecoid (Gsc), and Xenopus
nodal-related 3 (Xnr3), the anterior neural marker Otx2,
the anterior mesendodermal marker Xhex, the ventral
mesoderm marker Vent1, and the endodermal marker
Sox17. None of these markers was altered in XDbf4-
depleted embryos (Figures 5A and 5E). In contrast, in
stage 23–24 embryos from the same experiment, the
early heart markers Nkx2.5 and Tbx5 were sharply re-
duced (Figures 5B and 5C). Notably, XDbf4 depletion
did not affect the second major site of Tbx5 expression,
in the developing eyes, indicating that XDbf4 is required
for the regulation of this gene only in the heart (Figure5C). At stage 32, expression of troponin Ic (TnIc) was
also drastically decreased in XDMO1-injected embryos
(Figure 5D). Furthermore, whereas in wild-type embryos
TnIc expression encompassed a large triangular area in
the ventral midline, in XDMO1-injected embryos TnIc
transcripts were restricted to two diffuse lateral patches
(Figure 5D).
In contrast to XDMO-injected embryos, embryos in-
jected with a β-catenin morpholino (β-MO) exhibited
suppressed organizer genes Chd, Gsc, and Xnr3, and
decreased levels of Otx2 and Xhex (Figure 5E), in agree-
ment with earlier studies (Heasman et al., 2000;
Xanthos et al., 2002). Notably, expression levels of TnIc
and MHCα were only marginally affected (Figure 5E).
Consistent with the marker analysis, β-catenin-depleted
Developmental Cell
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(A) Analysis of early mesodermal markers in XDbf4-depleted embryos. Embryos were injected twice in the dorsal margin with XDMO1 (6
pmol) and XDMO2 (1 pmol), and hybridized with antisense RNA probes to chordin (Chd), goosecoid (Gsc), and Xhex. (B and C) Analysis of
early heart markers. Stage 23–25 embryos injected as in (A) were probed with Nkx2.5 (B) or Tbx5 (C) antisense RNAs. Arrowheads indicate
Tbx5 staining in the eye. (D) Analysis of TnIc. Stage 32 embryos injected as in (A) were probed with TnIc antisense RNA. Right two panels
show ventral views. (A–D) Results are representative of three different experiments with more than 15 embryos in each experimental group.
(E) XDbf4-depleted embryos reveal no change in early mesoderm or endoderm markers but a decrease in heart-specific markers. Embryos
were injected twice in the dorsal margin with XDMO1 (6 pmol) and XDMO2 (1 pmol), or with a β-catenin morpholino (βMO, 2 pmol), and RT-
PCR analysis was carried out at stage 10 or at stage 25, using primers specific for Chd, Gsc, Xnr3, Otx2, Xhex, Sox17, TnIc, MHCa, and
Vent1. EF1a is a control for loading. Duplicate samples, each corresponding to five embryos, are presented. Data representative of three
different experiments are shown. Uninj, uninjected embryos. -RT, no reverse transcriptase. (F) Morphological phenotypes of embryos analyzed
in (E). Heart and eye scores were as in Figure 4B. Dorsoanterior indices (DAI) were determined at stage 37. Data combined from two different
experiments are shown.embryos had relatively normal hearts but defective an- e
aterior structures (Figure 5F). In contrast, XDbf4-depleted
embryos had severely deficient hearts accompanied by s
frelatively normal general dorsoanterior development
(Figure 5F). These observations suggest that heart de- c
dfects in XDMO1-injected embryos are not likely to be
secondary consequences of an early dorsoanterior i
patterning defect.
Heart abnormalities in XDbf4-depleted embryos may T
Abe due to abnormal morphogenetic processes rather
than defective cell fate specification. To address this T
dpossibility, we analyzed elongation of XDbf4-depleted
animal cap explants in response to activin, a common X
mmodel for convergent extension (Sokol, 1996). Both
XDMO1-injected and control uninjected animal caps R
belongated equally well in the presence of activin, whereas
convergent extension was strongly suppressed in ex- m
fplants expressing Xdd1, a dominant-negative Dsh mu-
tant (Sokol, 1996) (Figure 6A). We next assessed extent t
(of mesendoderm involution in embryos injected with
XDMO1. Overall length of archenteron measured at sarly neurula stages was similar in XDMO1-injected
nd control embryos, while archenteron was much
horter in Xdd1-expressing embryos (Figure 6B). These
indings show that XDbf4 depletion does not affect
onvergent extension and mesendoderm involution
uring gastrulation, suggesting a specific role of XDbf4
n early cardiac induction.
he Effects of XDMO1 on Heart Development
re Specific
o confirm that the phenotype of XDMO1 was due to
epletion of the XDbf4 protein, we assessed whether
Dbf4 mRNA is able to restore normal levels of heart
arkers in XDMO1-injected embryos. We performed
T-PCR on dorsal marginal zone explants from em-
ryos injected first with XDMO1 and then with XDbf4
RNA lacking the MO target sequence. In explants
rom embryos injected with XDMO1 alone we observed
hat TnIc and MHCa levels were significantly reduced
Figure 7A). XDbf4 mRNA injection substantially re-
tored TnIc and MHCa expression (Figure 7A), indicat-
XDbf4, a Wnt Inhibitor in Heart Development
709Figure 6. Convergent Extension Movements and Archenteron
Length Are Not Affected in XDbf4-Depleted Embryos
(A) Depletion of XDbf4 does not affect convergent extension. Four-
cell stage embryos were injected four times animally with XDMO1
(6 pmol) and XDMO2 (1 pmol), or with Xdd1 mRNA (50 pg). At stage
9, animal cap explants (5–10 explants per experimental group) were
isolated and placed in the control 0.6× MMR medium or in the me-
dium containing 5 ng/ml of human activin A. Explants were photo-
graphed when control embryos reached stage 17. These results
were reproduced in three different experiments.
(B) Depletion of XDbf4 does not affect archenteron length. Unin-
jected embryos or embryos injected twice in the dorsal margin with
XDMO1 (6 pmol) or with Xdd1 mRNA (50 pg) were cultured until
stage 14, fixed, and sectioned mid-sagittally. Arrows point to
closed blastopore; arrowheads indicate anterior-most limit of themordia. These morphological defects are likely to be
archenteron. Top graph shows average angles formed by the ante-
rior limit of the archenteron, geometric center of the embryo, and
the small yolk plug (as shown in the bottom panel). Bottom graph
indicates average distance from the yolk plug to the anterior limit
of the archenteron (dashed red line). Data are representative of two
different experiments with 10–15 embryos in each experimental
group.ing that the effects of the XDMO1 on heart development
are due solely to depletion of XDbf4. Moreover, we ob-
served a partial rescue of morphological heart defects
in XDMO1-injected embryos by Myc-XDbf4mRNA (Fig-
ure 7B), further supporting the specificity of the knock-
down phenotype.
The XDbf4-MC Mutant Rescues the XDMO1-
Induced Reduction of Heart Marker Expression
Taken together, the in situ and RT-PCR data indicate
that depletion of XDbf4 results in severe defects in
heart specification and morphogenesis. These defects
could be due to an effect of XDbf4 on the cell cycle, or
due to inhibition of Wnt signaling. To answer this ques-
tion we utilized the XDbf4-MC mutant to rescue the
XDMO1-induced reduction in TnIc levels. We observed
that the XDbf4-MC mutant restored TnIc expression
(Figure 7C). Since XDbf4-MC downregulates Wnt sig-
naling and suppresses the effect of XDMO1 on reporter
activity (Figures 2D and 3E), but lacks domains involved
in activating Cdc7, our results suggest that the interac-
tion of Cdc7 with XDbf4 is not relevant in heart devel-
opment.
Functional Synergy of XDbf4 and Frodo
As XDbf4 physically associates with Frodo in vivo (Fig-
ure 1B), we investigated whether these proteins interact
functionally in heart and eye formation by lowering
levels of both proteins simultaneously. We compared
the phenotypes of embryos injected with a Frodo mor-
pholino (FrdMO), XDMO1, or both. Depletion of Frodo
in animal pole blastomeres has been shown to lead to
severe defects in eye and central nervous system de-
velopment (Gloy et al., 2002; Hikasa and Sokol, 2004).
Notably, embryos injected marginally with low doses of
FrdMO (0.09 pmol) often had small hearts and edema
characteristic of XDbf4-depleted embryos (Figures 7D
and 7E). The majority of embryos injected with a low
dose of XDMO1 (0.2 pmol) were normal (Figures 7D and
7E). In contrast to the effect of individual morpholinos,
coinjection of FrdMO and XDMO1 resulted in embryos
with small eyes, acute edema, and virtually no visible
heart tissue (Figures 7D and 7E). These experiments
show that Frodo and XDbf4 cooperate during heart and
eye development.
Discussion
XDbf4 Is a Wnt Inhibitor Crucial for Early
Heart Specification
This study identifies XDbf4 as a regulator of heart de-
velopment. XDbf4-depleted embryos exhibit small
hearts and incomplete fusion of the bilateral heart pri-
Developmental Cell
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(A) XDbf4 mRNA restores heart markers downregulated by XDMO1. Left panel, four-cell embryos were injected twice in the dorsal margin
with XDMO1 (6 pmol), or with XDMO1 followed by XDbf4 mRNA (750 pg) that lacks XDMO1 target sequences. RT-PCR for TnIc, MHCα, and
EF1α was performed on total mRNA from dorsal marginal zone (DMZ) explants isolated at stage 10 and cultured in vitro until stage 30. EF1α
is a control for loading. (-), uninjected DMZ explants; WE, whole embryos; –RT, whole embryos with no reverse transcriptase. Right panel,
pooled data from three separate experiments, with five explants combined in each sample. Means ± standard deviations of relative TnIc
levels are shown. The highest TnIc level in uninjected DMZ explants was assumed 100%. The difference between XDMO1-injected and
XDMO1 plus XDbf4 RNA-injected groups is significant (p < 0.05).
(B) Myc-XDbf4 mRNA partially rescues morphological heart defects in XDMO1-injected embryos. Embryos were injected as in (A) and scored
for heart defects at stage 38–40 as described in Figure 4B legend. Means and standard deviations correspond to one of three independent
experiments; *, statistically different from ** (p < 0.05).
(C) XDbf4-MC restores TnIc expression in XDMO1-injected embryos. Left panel, embryos were injected with XDMO1 followed by H2O or
XDbf4-MC mRNA (MC, 2 ng) as indicated. Embryo injections, explants, and RT-PCR were done as in (A). Lower levels of TnIc are shown
in ventral marginal zone (VMZ) explants for comparison. Right panel, pooled data from four separate experiments, with five explants combined
in each sample. Means ± standard deviations of relative TnIc levels are shown. The highest TnIc level in uninjected DMZ explants was
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711caused by the observed suppression of the early
cardiac genes Nkx2.5 and Tbx5 and the late marker
TnIc. Our data suggest that XDbf4 is specifically re-
quired for heart development, since neither archen-
teron involution nor convergent extension or early
molecular markers of dorsoanterior-ventroposterior
patterning were affected (Figures 5 and 6). We have not
observed induction of heart markers in the ventral-mar-
ginal region by overexpressed XDbf4 (data not shown),
suggesting that XDbf4 is required but not sufficient for
cardiogenesis.
Several proteins involved in heart tube fusion are also
required for endoderm differentiation (Alexander et al.,
1999; Kikuchi et al., 2000; Reiter et al., 1999; Schier et
al., 1997), supporting the essential role of endodermal
signals in heart induction and morphogenesis (Jacob-
son, 1960; Lough and Sugi, 2000; Schneider and Mer-
cola, 1999). Thus, XDbf4 may influence endodermal de-
velopment, thereby affecting heart morphogenesis, or
may act within presumptive cardiac mesoderm. To dis-
sect out the requirement for XDbf4 in these tissues, we
specifically depleted XDbf4 in early blastomeres fated
to become either endoderm or mesoderm. Depletion
of XDbf4 in the most vegetal blastomeres (presumptive
endoderm) led to a less severe heart phenotype, com-
pared with injections into the dorsal and dorsolateral
marginal zone (Figures 4E–4H). Moreover, we did not
detect any changes in several mesendoderm markers
in XDbf4-depleted embryos (Figures 5A and 5E). Thus,
our findings indicate a primary role for XDbf4 in cardiac
mesoderm rather than endoderm or organizer-derived
mesoderm.
The identification of XDbf4 as a Wnt inhibitor estab-
lishes a requirement for downregulation of canonical
Wnt signaling in early cardiogenesis. In zebrafish em-
bryos with mutated APC, heart specification was not
altered, although later abnormalities in endocardial dif-
ferentiation were observed (Hurlstone et al., 2003).
Loss-of-function mutations in other genes encoding
Wnt antagonists cause early axial patterning defects
that obscure heart-specific phenotypes (Gluecksohn-
Schoenheimer, 1949; Ishikawa et al., 2003; Kofron et al.,
2001; Merrill et al., 2004; Zeng et al., 1997). A mouse
Dkk1 null mutant lacks anterior head structures and ex-
hibits limb defects, but has functional hearts (Mukho-
padhyay et al., 2001). In contrast, our study demon-
strates that a canonical Wnt signaling inhibitor is
required for heart development.
Mechanism for XDbf4-Mediated Repression
of Wnt Signaling
We show that XDbf4 inhibits signaling by β-catenin and
TCF-VP16, a β-catenin-independent transcriptional ac-
tivator (Vonica et al., 2000; Figure 2). These data sug-
gest that XDbf4 functions at the level of target gene dual function in heart development, repressing canoni-
assumed 100%.
(D and E) Frodo and XDbf4 synergize to regulate heart and eye development. Four-cell embryos were injected twice in the dorsal margin with
FrdMO (0.09 pmol) and CMO (0.2 pmol), or CMO (0.09 pmol) and XDMO1 (0.2 pmol), or FrdMO (0.09 pmol) and XDMO1 (0.2 pmol) as
indicated. At stage 40, embryos were scored for heart and eye defects as described in Figure 4B. Control uninjected embryos are shown. (D)
Representative embryos. (E) Quantitation of phenotypes with means and standard deviations shown. *, significantly different from ** (p <
0.01). Similar results were obtained in four different experiments.regulation. In fact, XDbf4 physically associates with
Frodo, which acts in the Wnt pathway through its in-
teraction with TCF (Hikasa and Sokol, 2004). As XDbf4
binds chromatin in Xenopus oocytes (Furukohri et al.,
2003), it may modify chromatin structure, maintaining it
in a “closed” conformation that inhibits TCF/β-catenin-
mediated transcription. Several studies have high-
lighted the importance of chromatin remodeling in ca-
nonical Wnt signaling (Barker et al., 2001; Feng et al.,
2003; Hecht et al., 2000; Tutter et al., 2001). In this sce-
nario, Frodo might function as a cofactor directing
XDbf4 to Wnt-responsive promoters.
The synergy of the XDbf4 and Frodo morpholinos
(Figures 7D and 7E) demonstrates a functional interac-
tion between the two proteins and supports the idea
that the two proteins act in the same complex. Since
FrdMO enhances the effect of XDMO, Frodo may act
similarly to XDbf4 as a Wnt inhibitor. Frodo and Dapper,
a closely related protein, were recently reported to
function as context-dependent regulators of signaling,
which activated TCF3-dependent transcription but in-
hibited Wnt8-ligand-dependent signaling (Hikasa and
Sokol, 2004; Waxman et al., 2004). The synergy be-
tween XDbf4 and Frodo indicates that both proteins
function as negative regulators of Wnt signaling in the
context of heart development. Notably, Frodo, but not
XDbf4, is also involved in early patterning and morpho-
genesis (Hikasa and Sokol, 2004). Thus, these two sig-
naling mediators may have diverse roles in different de-
velopmental processes.
A Role for XDbf4 in Heart Development: Wnt
Signaling versus Cell Cycle Regulation
XDbf4 has been shown to bind and activate Cdc7, a
kinase required for progression of cells through S
phase of the cell cycle (Furukohri et al., 2003). Do ob-
served heart defects in XDbf4-depleted embryos result
from the effect of XDbf4 on Wnt signaling or the cell
cycle? The XDbf4-MC mutant lacking the domains re-
quired for activation of Cdc7 (Masai and Arai, 2000;
Ogino et al., 2001) was able to rescue heart marker ex-
pression in XDbf4-depleted DMZ explants. Since
XDbf4-MC inhibits β-catenin signaling, XDbf4 function
in heart development is likely to involve Wnt inhibition
and does not require its interaction with Cdc7.
We have not detected a change in cell size in XDbf4-
depleted embryos, indicating no inhibition of cell divi-
sion. The lack of cell cycle defects could be explained
by the presence of Drf1, a second family member that
may have a redundant function (Montagnoli et al., 2002;
Yanow et al., 2003). Lacking direct evidence, the possi-
bility remains that XDbf4 is required for progenitor cell
proliferation, which may be critical for cardiogenesis
(Yelon et al., 2000). For instance, XDbf4 might have a
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712pcal Wnt signaling while assisting cardiac precursor divi-
qsion. One precedent is the chromatin-associated heli-
Fcase Reptin (Rottbauer et al., 2002). A mutation of
M
zebrafish Reptin has enhanced Wnt inhibitory activity 4
and leads to overproliferation of ventricular cardiomyo- D
mcytes (Rottbauer et al., 2002). Future studies will ex-
Splore the connection between the role of XDbf4 in Wnt




Isolation of XDbf4 cDNA and DNA Constructs a
Proteins interacting with Frodo were isolated in a yeast two-hybrid f
screen from a Xenopus gastrula library (Itoh et al., 2000) in pJG4-5, a
as described (Gyuris et al., 1993). Five independent clones were a
isolated that contained the full-length XDbf4 cDNA. For expression w
of XDbf4 in Xenopus embryos, the XDbf4 cDNA insert was sub- s
cloned into EcoR1 and XhoI sites of pCS2+MT (Turner and
Weintraub, 1994) using PCR with the primers: 5#-CGGAATTCGTGAA
GAATCCGACTGGA-3# and 5#-CCGCTCGAGTTAAAAGCCAAGAAA I
CGAAGA-3#. pCS2+MT-XDbf4 does not possess sequences tar- a
geted by XDMO1and XDMO2, and was used as a template for I
XDbf4 mRNA synthesis in all experiments, except where indicated H
otherwise. In addition, pCT-XDbf4 encoding the 5#-untranslated re- D
gion of XDbf4 cDNA was used for in vitro translation. pCT has been z
derived from pCS2 with the positions of the T7 and SP6 promoters s
switched by PCR. pCT and pCTX-HA-XDbf4 were digested with w
BamHI and XhoI and ligated together. XDbf4-MC is an internal w
deletion of pCS2+MT-XDbf4 at PstI sites. This results in deletion of (
amino acids 208 to 584. Because of difficulties in expression of a
full-length Frodo, we made pCTX-HA-FrdB by subcloning a DNA 1
fragment spanning Frodo amino acids 198 to 337 into pCTX-HA, a e
modified form of pCT containing a hemagglutinin (HA) tag. Details o
of cloning are available upon request. c
m
Embryo Microinjections and Analysis
For mRNA synthesis, DNA templates were linearized with the fol-
lowing restriction enzymes: pCS2+MT-XDbf4 with SacII; pCTX-HA- E
PFrdB with SalI; pCS2-Flag-βCat (Liu et al., 1999); pCS2-Myc-Dsh,
Xdd1 (Sokol, 1996); XTCF-VP16 (Vonica et al., 2000) with NotI; A
wpEGFP-C1-PXT7 with SacII; pCS2-Xnr1 (Jones et al., 1995) and
pCS2-β-Gal with Asp718. Capped synthetic mRNAs were gener- i
wated by in vitro transcription with SP6 polymerase, using the
mMessage mMachine kit (Ambion) as described by the manufac- (
eturer. mRNA was quantified by measuring the OD260 and by com-
paring in a gel with a standard of known concentration. e
oEmbryos were obtained from Xenopus females and cultured in
0.1× Marc’s modified Ringer’s medium (MMR) as described pre- s
sviously by Newport and Kirschner (1982). Embryonic stages were
determined according to Nieuwkoop and Faber (1967). For microin- C
Tjections, four-cell embryos were transferred to 3% Ficoll 400 (Phar-
macia) in 0.5× MMR and injected with 10 nl of the specified amount A
Cof RNA. A mRNA corresponding to the cDNA for Xenopus Nedd1
(Kumar et al., 1994) was used as a control in Figure 2C. Embryos G
Cwere cultured until stages 36–38, and then fixed with MEMFA
(0.1 M MOPS, 2 mM EGTA [pH 8.0], 1 mM MgSO4, and 3.7% formal- 5
Tdehyde)(Harland, 1991) for scoring morphological changes and im-
aging. Heart and eye defects were scored in live embryos at stage T
G43. For lineage tracing, LacZ RNA encoding nuclear β-galactosi-
dase was injected together with morpholinos at 20 pg/embryo, and G
5β-galactosidase activity was visualized with the RedGal substrate
(Research Organics). All experiments were reproduced at least T
wthree times.
Antisense morpholinos were from Gene Tools (Oregon). XDbf4 a
cmorpholinos were designed to nonoverlapping regions of XDbf4
RNA and have the following sequences: XDMO1, 5#-CACTGCTGC e
gTATGGTAGATTTCATT-3#; XDMO2, 5#-CCATGTGTTCCTCGGTTTC
TGTGCA-3#. β-catenin morpholino had the following sequence: 5#- v
ITTTCAACCGTTTCCAAAGAACCAGG-3#. The control morpholinos
have the following sequences: (CMO, 5#-ATGGCGGATTGAGTGCA a
jGCAGCCTA-3#, CMO2, 5#-ATCGACTTCCTCCGAAACGGACATG-3#,
and CMO3, 5#-AACCAGTTTCTGAGGTCATGATTTG-3#. These mor- tholinos have similar base composition but different primary se-
uence and target three uncharacterized Xenopus mRNAs. The
rodo morpholino has been previously described (Gloy et al., 2002).
orpholinos were injected into Xenopus embryos at the 2- to
-cell stage. In all rescue and reporter experiments, mRNAs and
NAs were injected into embryos at the 4- to 8-cell stage following
orpholino injections. Statistical significance was analyzed by the
tudent’s t test.
uciferase Activity Measurements
mbryos were injected twice ventral-animally with 20 pg pSia-Luc
Fan et al., 1998), TOPflash, or FOPflash (Korinek et al., 1998) DNA
long with the indicated amounts of mRNA. At stage 10, sets of
ive embryos were lysed in 100 l of 50 mM Tris (pH 7.4) and spun
t 12,000 g for 5 min. Supernatants were assayed for luciferase
ctivity as previously described (Fan et al., 1998). Experiments
ere repeated at least three times; representative experiments are
hown.
n Situ Hybridization Analysis, Embryo Sectioning,
nd Staining
n situ hybridization was performed essentially as described by
arland (1991). For making digoxygenin antisense RNA probes,
NA templates were linearized with the following restriction en-
ymes: pGEM3Z-Nkx2.5 with HindIII (Tonissen et al., 1994); pBlue-
cript SK-TnIc with NotI (Drysdale et al., 1994); pCTX-HA-XDbf4
ith EcoRI; pGsc with XhoI (Cho et al., 1991); pBluescript-XTbx5
ith SacI (Horb and Thomsen, 1999); pBluescript-Xhex with NotI
Newman et al., 1997); and pBluescript-Chd with EcoRI (Sasai et
l., 1994). Fixed embryos were embedded in paraffin, sectioned at
0–17 m, and some sections were stained with hematoxylin and
osin as described by Sokol et al. (1990). For histological staining
f RedGal-labeled embryos, rehydrated embryo sections were in-
ubated in 0.5% Methyl Green solution for 4 min, dehydrated, and
ounted for brightfield microscopy.
xplants and Reverse Transcriptase-Dependent
olymerase Chain Reaction
nimal cap explant assays with human activin A were performed
ith 5–10 explants per group as described (Sokol, 1993). Embryos
njected with XDbf4 morpholino and mRNAs as described above
ere dissected at stage 10 for dorsal- or ventral-marginal zone
MZ) explants and cultured in 0.8× MMR until stage 30. mRNA from
xplants was isolated as described by Itoh et al. (1998a); five MZ
xplants were used for each sample. cDNA was synthesized using
ligo-(dT)12-18 primer, SuperScriptTMII RNaseH- Reverse Tran-
criptase, and RNase H (Invitrogen). PCR primers had the following
equences. For TnIc, + 5#-CTGATGAGGAAGAGGTAACC-3#, - 5#CCT
ACGTTCCATTTCTGCC-3#; MHCa, + 5#-GCCAACGCGAACCTC
CCAAGT TCCG-3#, - 5#-GGTCACATTTTATTTCATGCTGGTTAAC
GG-3#; Otx2, +5#-GAGGCCAAAACAAAGTGAGA-3#, -5#-ACAGT
CATACCCCCAAAG-3#; chordin, + 5#-AACTGCCAGGACTGGAT
GT-3#, - 5#-GGCAGGATTTAGAGTTGCTTC-3#; Xnr3, + 5#-CGAGTG
AAGAAGGTGGACA-3#, -5#-ATCTTCATGGGGACACAGGA-3#; gsc, +
#-TTCACCGATGAACAACTGGA-3#, -5#-TTCCACTTTTGGGCATT
TC-3#; vent1, +5#-GCATCTCCTTGGCATATTTGG-3#, -5#-TTCCCT
CAGCATGGTTCACC-3#; Xhex, + 5#-AACAGCGCATCTAATGG
AC-3#, - 5#-CCTTTCCGCTTGTGCAGAGG-3#; Sox17, + 5#-GTCAT
GTAGGAGAGAAC-3#, - 3#-ATCTGTTTAGCCATCACTG-3#; EF1a, +
#-CAGATTGGTGCTGGATATGC-3#, - 5#-ACTGCCTTGATGACTCC
AG-3#. PCR conditions were as follows. An initial denaturing step
as performed at 94°C for 3 min and then samples were incubated
t 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min, for 23–28
ycles. A final extension step was at 72°C for 5 min. One-half of
ach PCR reaction was electrophoresed on a 5% polyacrylamide
el, stained with ethidium bromide, and photographed under ultra-
iolet light. For quantitation of RT-PCR results, the Science Lab 98
mage Gauge program (Fuji Film) was used. Data were expressed
s a percentage of values obtained for TnIc expression in unin-
ected DMZ explants. All experiments were performed at least
hree times.
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713Western Analysis, Antibodies, and In Vitro Translation
Groups of 10 embryos were lysed in 200 l of lysis buffer (1% Triton
X-100, 50 mM Tris-HCl [pH 7.5], 50 mM NaCl, 1 mM EDTA, 0.1 mM
phenylmethylsulfonylfluoride, 10 mM NaF, and 1 mM Na3VO4). After
spinning at 16,000 g for 5 min, samples were heated at 100°C in
sample buffer for 3 min and electrophoresed on 10% sodium-
dodecylsulfate polyacrylamide gels (SDS-PAGE). The equivalent of
0.25 embryos was loaded per lane. Proteins were transferred to
Immobilon-P membranes (Millipore) and probed with anti-XDbf4N
polyclonal antibodies (Furukohri et al., 2003), anti-HA 12CA5
(Babco), or anti-Myc 9E10 (ATCC) monoclonal antibodies, as pre-
viously described (Itoh et al., 1998b). Whole mount immunostaining
was performed essentially as described (Hemmati-Brivanlou et al.,
1990). Anti-actin antibody was from BioGenix. In vitro translation
reactions were performed using rabbit reticulocyte lysates from the
Retic Lysate IVTTM kit (Ambion) as described by the manufacturer.
[35S]-L-methionine was from NEN. Radiolabeled lysates were elec-
trophoresed on SDS-PA gels as described above, gels were fixed
in 50% methanol and 10% acetic acid, dried, and exposed to
XAR-5 film (Kodak) for autoradiography.
Acknowledgments
We thank H. Clevers, E. DeRobertis, B. Gumbiner, P. Krieg, R. Har-
land, X. He, G. Thomsen, A. Vonica, and C. Wright for plasmids. We
are grateful to Ronit Yelin for help with in situ hybridization and her
contribution to Figure 5. We thank Shou Waga for the generous gift
of anti-XDbf4 antibodies. We also thank S. Baccus, K. Itoh, E. Jo-
seph, and T. Schultheiss for critical reading of the manuscript, and
members of the Sokol lab for helpful discussions. This work has
been supported by National Institutes of Health grants to S.Y.S.
Received: May 18, 2004
Revised: January 24, 2005
Accepted: February 11, 2005
Published: April 3, 2005
References
Alexander, J., Rothenberg, M., Henry, G.L., and Stainier, D.Y. (1999).
casanova plays an early and essential role in endoderm formation
in zebrafish. Dev. Biol. 215, 343–357.
Barker, N., Hurlstone, A., Musisi, H., Miles, A., Bienz, M., and Clev-
ers, H. (2001). The chromatin remodelling factor Brg-1 interacts
with beta-catenin to promote target gene activation. EMBO J. 20,
4935–4943.
Brannon, M., Gomperts, M., Sumoy, L., Moon, R.T., and Kimelman,
D. (1997). A beta-catenin/XTcf-3 complex binds to the siamois pro-
moter to regulate dorsal axis specification in Xenopus. Genes Dev.
11, 2359–2370.
Chen, J.N., and Fishman, M.C. (1996). Zebrafish tinman homolog
demarcates the heart field and initiates myocardial differentiation.
Development 122, 3809–3816.
Chen, J.N., Haffter, P., Odenthal, J., Vogelsang, E., Brand, M., van
Eeden, F.J.M., Furutani-Seiki, M., Granato, M., Hammerschmidt, M.,
Heisenberg, C.-P., et al. (1996). Mutations affecting the cardiovas-
cular system and other internal organs in zebrafish. Development
123, 293–302.
Cheyette, B.N., Waxman, J.S., Miller, J.R., Takemaru, K., Sheldahl,
L.C., Khlebtsova, N., Fox, E.P., Earnest, T., and Moon, R.T. (2002).
Dapper, a Dishevelled-associated antagonist of beta-catenin and
JNK signaling, is required for notochord formation. Dev. Cell 2,
449–461.
Cho, K.W., Blumberg, B., Steinbeisser, H., and De Robertis, E.M.
(1991). Molecular nature of Spemann’s organizer: the role of the
Xenopus homeobox gene goosecoid. Cell 67, 1111–1120.
Dale, L., and Slack, J.M.W. (1987). Fate map for the 32-cell stage
of Xenopus laevis. Development 99, 527–551.
Drysdale, T.A., Tonissen, K.F., Patterson, K.D., Crawford, M.J., and
Krieg, P.A. (1994). Cardiac troponin I is a heart-specific marker inthe Xenopus embryo: expression during abnormal heart morpho-
genesis. Dev. Biol. 165, 432–441.
Fan, M.J., Gruning, W., Walz, G., and Sokol, S.Y. (1998). Wnt signal-
ing and transcriptional control of Siamois in Xenopus embryos.
Proc. Natl. Acad. Sci. USA 95, 5626–5631.
Feng, Y., Lee, N., and Fearon, E.R. (2003). TIP49 regulates beta-
catenin-mediated neoplastic transformation and T-cell factor target
gene induction via effects on chromatin remodeling. Cancer Res.
63, 8726–8734.
Fishman, M.C., and Chien, K.R. (1997). Fashioning the vertebrate
heart: earliest embryonic decisions. Development 124, 2099–2117.
Furukohri, A., Sato, N., Masai, H., Arai, K., Sugino, A., and Waga,
S. (2003). Identification and characterization of a Xenopus homolog
of Dbf4, a regulatory subunit of the Cdc7 protein kinase required for
the initiation of DNA replication. J. Biochem. (Tokyo) 134, 447–457.
Glickman, N.S., and Yelon, D. (2002). Cardiac development in ze-
brafish: coordination of form and function. Semin. Cell Dev. Biol.
13, 507–513.
Glinka, A., Wu, W., Delius, H., Monaghan, A.P., Blumenstock, C.,
and Niehrs, C. (1998). Dickkopf-1 is a member of a new family of
secreted proteins and functions in head induction. Nature 391,
357–362.
Gloy, J., Hikasa, H., and Sokol, S.Y. (2002). Frodo interacts with
Dishevelled to transduce Wnt signals. Nat. Cell Biol. 4, 351–357.
Gluecksohn-Schoenheimer, S. (1949). The effects of a lethal muta-
tion responsible for duplications and twinning in mouse embryos.
J. Exp. Zool. 110, 47–76.
Grow, M.W., and Krieg, P.A. (1998). Tinman function is essential for
vertebrate heart development: elimination of cardiac differentiation
by dominant inhibitory mutants of the tinman-related genes,
XNkx2-3 and XNkx2-5. Dev. Biol. 204, 187–196.
Gyuris, J., Golemis, E., Chertkov, H., and Brent, R. (1993). Cdil, a
human G1 and S phase protein phosphatase that associates with
Cdk2. Cell 75, 791–803.
Harland, R., and Gerhart, J. (1997). Formation and function of
Spemann’s organizer. Annu. Rev. Cell Dev. Biol. 13, 611–667.
Harland, R.M. (1991). In situ hybridization: an improved whole-
mount method for Xenopus embryos. In Methods in Cell Biology,
B.K. Kay and H.B. Peng, eds. (San Diego: Academic Press), pp.
685–695.
Heasman, J., Kofron, M., and Wylie, C. (2000). Beta-catenin signal-
ing activity dissected in the early Xenopus embryo: a novel anti-
sense approach. Dev. Biol. 222, 124–134.
Hecht, A., Vleminckx, K., Stemmler, M.P., van Roy, F., and Kemler,
R. (2000). The p300/CBP acetyltransferases function as transcrip-
tional coactivators of beta-catenin in vertebrates. EMBO J. 19,
1839–1850.
Hemmati-Brivanlou, A., Stewart, R.M., and Harland, R.M. (1990).
Region-specific neural induction of an engrailed protein by anterior
notochord in Xenopus. Science 250, 800–802.
Hikasa, H., and Sokol, S.Y. (2004). The involvement of Frodo in TCF-
dependent signaling and neural tissue development. Development
131, 4725–4734.
Horb, M.E., and Thomsen, G.H. (1999). Tbx5 is essential for heart
development. Development 126, 1739–1751.
Hurlstone, A.F., Haramis, A.P., Wienholds, E., Begthel, H., Korving,
J., Van Eeden, F., Cuppen, E., Zivkovic, D., Plasterk, R.H., and Clev-
ers, H. (2003). The Wnt/beta-catenin pathway regulates cardiac
valve formation. Nature 425, 633–637.
Ishikawa, T.O., Tamai, Y., Oshima, M., and Taketo, M.M. (2003).
Requirement for tumor suppressor Apc in the morphogenesis of
anterior and ventral mouse embryo. Dev. Biol. 253, 230–246.
Itoh, K., Jacob, J., and Sokol, S.Y. (1998a). A role for Xenopus Friz-
zled 8 in dorsal development. Mech. Dev. 74, 145–157.
Itoh, K., Krupnik, V.E., and Sokol, S.Y. (1998b). Axis determination
in Xenopus involves biochemical interactions of axin, glycogen
synthase kinase 3 and beta-catenin. Curr. Biol. 8, 591–594.
Itoh, K., Antipova, A., Ratcliffe, M.J., and Sokol, S. (2000). Interac-
Developmental Cell
714tion of dishevelled and Xenopus axin-related protein is required for M
nwnt signal transduction. Mol. Cell. Biol. 20, 2228–2238.
3Jackson, A.L., Pahl, P.M., Harrison, K., Rosamond, J., and Sclafani,
MR.A. (1993). Cell cycle regulation of the yeast Cdc7 protein kinase
Xby association with the Dbf4 protein. Mol. Cell. Biol. 13, 2899–2908.
MJacobson, A.G. (1960). Influences of ectoderm and endoderm on
Theart differentiation in the newt. Dev. Biol. 2, 138–154.
aJiang, Y., and Evans, T. (1996). The Xenopus GATA-4/5 genes are
iassociated with cardiac specification and can regulate cardiac
4transcription during embryogenesis. Dev. Biol. 174, 258–270.
NJones, C.M., Keuhn, M.R., Hogan, B.L.M., Smith, J.C., and Wright,
gC.V.E. (1995). Nodal-related signals induce axial mesoderm and
ldorsalize mesoderm during gastrulation. Development 121, 3651–
c3662.
NKao, K.R., and Elinson, R.P. (1988). The entire mesodermal mantle
sbehaves as Spemann’s organizer in dorsoanterior enhanced Xeno-
cpus laevis embryos. Dev. Biol. 127, 64–77.
NKelley, C., Blumberg, H., Zon, L.I., and Evans, T. (1993). GATA-4 is
la novel transcription factor expressed in endocardium of the de-
Nveloping heart. Development 118, 817–827.
GKikuchi, Y., Trinh, L.A., Reiter, J.F., Alexander, J., Yelon, D., and
OStainier, D.Y. (2000). The zebrafish bonnie and clyde gene encodes
aa Mix family homeodomain protein that regulates the generation of
vendodermal precursors. Genes Dev. 14, 1279–1289.
3Kofron, M., Klein, P., Zhang, F., Houston, D.W., Schaible, K., Wylie,
OC., and Heasman, J. (2001). The role of maternal axin in patterning
othe Xenopus embryo. Dev. Biol. 237, 183–201.
PKomada, M., and Soriano, P. (1999). Hrs, a FYVE finger protein lo-
1calized to early endosomes, is implicated in vesicular traffic and
frequired for ventral folding morphogenesis. Genes Dev. 13, 1475–
1485. P
rKorinek, V., Barker, N., Willert, K., Molenaar, M., Roose, J., Wagen-
aar, G., Markman, M., Lamers, W., Destree, O., and Clevers, H. P
(1998). Two members of the Tcf family implicated in Wnt/beta- C
catenin signaling during embryogenesis in the mouse. Mol. Cell. v
Biol. 18, 1248–1256. P
Kumagai, H., Sato, N., Yamada, M., Mahony, D., Seghezzi, W., Lees, s
E., Arai, K., and Masai, H. (1999). A novel growth- and cell cycle- f
regulated protein, ASK, activates human Cdc7-related kinase and 1
is essential for G1/S transition in mammalian cells. Mol. Cell. Biol. R
19, 5083–5095. H
Kumar, S., Matsuzaki, T., Yoshida, Y., and Noda, M. (1994). Molecu- o
lar cloning and biological activity of a novel developmentally regu- 2
lated gene encoding a protein with beta-transducin-like structure. R
J. Biol. Chem. 269, 11318–11326. Z
Lickert, H., Kutsch, S., Kanzler, B., Tamai, Y., Taketo, M.M., and R
Kemler, R. (2002). Formation of multiple hearts in mice following f
deletion of beta-catenin in the embryonic endoderm. Dev. Cell 3, S
171–181. a
Liu, C., Kato, Y., Zhang, Z., Do, V.M., Yankner, B.A., and He, X. c
(1999). beta-Trcp couples beta-catenin phosphorylation-degrada- m
tion and regulates Xenopus axis formation. Proc. Natl. Acad. Sci. S
USA 96, 6273–6278. R
Logan, M., and Mohun, T. (1993). Induction of cardiac muscle differ- a
entiation in isolated animal pole explants of Xenopus laevis em- S
bryos. Development 118, 865–875. W
Lough, J., and Sugi, Y. (2000). Endoderm and heart development. e
Dev. Dyn. 217, 327–342. o
Marvin, M.J., Di Rocco, G., Gardiner, A., Bush, S.M., and Lassar, S
A.B. (2001). Inhibition of Wnt activity induces heart formation from h
posterior mesoderm. Genes Dev. 15, 316–327. 8
Masai, H., and Arai, K.-I. (2000). Dbf4 motifs: conserved motifs in S
activation subunits for Cdc7 kinase essential for S-phase. Bio- c
chem. Biophys. Res. Commun. 275, 228–232. S
Merrill, B.J., Pasolli, H.A., Polak, L., Rendl, M., Garcia-Garcia, M.J., p
Anderson, K.V., and Fuchs, E. (2004). Tcf3: a transcriptional regula- r
tor of axis induction in the early embryo. Development 131, 263– 1
274. S
iMontagnoli, A., Bosotti, R., Villa, F., Rialland, M., Brotherton, D.,ercurio, C., Berthelsen, J., and Santocanale, C. (2002). Drf1, a
ovel regulatory subunit for human Cdc7 kinase. EMBO J. 21,
171–3181.
oody, S.A. (1987). Fates of the blastomeres of the 32-cell-stage
enopus embryo. Dev. Biol. 122, 300–319.
ukhopadhyay, M., Shtrom, S., Rodriguez-Esteban, C., Chen, L.,
sukui, T., Gomer, L., Dorward, D.W., Glinka, A., Grinberg, A., Hu-
ng, S.P., et al. (2001). Dickkopf1 is required for embryonic head
nduction and limb morphogenesis in the mouse. Dev. Cell 1, 423–
34.
ewman, C.S., Chia, F., and Krieg, P.A. (1997). The XHex homeobox
ene is expressed during development of the vascular endothe-
ium: overexpression leads to an increase in vascular endothelial
ell number. Mech. Dev. 66, 83–93.
ewport, J., and Kirschner, M. (1982). A major developmental tran-
ition in early Xenopus embryos. I. Characterization and timing of
ellular changes at the midblastula stage. Cell 30, 675–686.
ieuwkoop, P.D., and Faber, J. (1967). Normal Table of Xenopus
aevis (Daudin) (Amsterdam: North Holland).
usse, R. (1999). WNT targets. Repression and activation. Trends
enet. 15, 1–3.
gino, K., Takeda, T., Matsui, E., Iiyama, H., Taniyama, C., Arai, K.,
nd Masai, H. (2001). Bipartite binding of a kinase activator acti-
ates Cdc7-related kinase essential for S phase. J. Biol. Chem. 276,
1376–31387.
lson, E.N., and Schneider, M.D. (2003). Sizing up the heart: devel-
pment redux in disease. Genes Dev. 17, 1937–1956.
andur, P., Lasche, M., Eisenberg, L.M., and Kuhl, M. (2002). Wnt-
1 activation of a non-canonical Wnt signalling pathway is required
or cardiogenesis. Nature 418, 636–641.
asumarthi, K.B., and Field, L.J. (2002). Cardiomyocyte cell cycle
egulation. Circ. Res. 90, 1044–1054.
atterson, K.D., Cleaver, O., Gerber, W.V., Grow, M.W., Newman,
.S., and Krieg, P.A. (1998). Homeobox genes in cardiovascular de-
elopment. Curr. Top. Dev. Biol. 40, 1–44.
era, E.M., and De Robertis, E.M. (2000). A direct screen for
ecreted proteins in Xenopus embryos identifies distinct activities
or the Wnt antagonists Crescent and Frzb-1. Mech. Dev. 96, 183–
95.
eiter, J.F., Alexander, J., Rodaway, A., Yelon, D., Patient, R.,
older, N., and Stainier, D.Y. (1999). Gata5 is required for the devel-
pment of the heart and endoderm in zebrafish. Genes Dev. 13,
983–2995.
ottbauer, W., Saurin, A.J., Lickert, H., Shen, X., Burns, C.G., Wo,
.G., Kemler, R., Kingston, R., Wu, C., and Fishman, M. (2002).
eptin and Pontin antagonistically regulate heart growth in zebra-
ish embryos. Cell 111, 661–672.
aga, Y., Miyagawa-Tomita, S., Takagi, A., Kitajima, S., Miyazaki, J.,
nd Inoue, T. (1999). MesP1 is expressed in the heart precursor
ells and required for the formation of single heart tube. Develop-
ent 126, 3437–3447.
asai, Y., Lu, B., Steinbeisser, H., Geissert, D., Gont, L.K., and De
obertis, E.M. (1994). Xenopus chordin: a novel dorsalizing factor
ctivated by organizer-specific homeobox genes. Cell 79, 779–790.
chier, A.F., Neuhauss, S.C., Helde, K.A., Talbot, W.S., and Driever,
. (1997). The one-eyed pinhead gene functions in mesoderm and
ndoderm formation in zebrafish and interacts with no tail. Devel-
pment 124, 327–342.
chneider, V.A., and Mercola, M. (1999). Spatially distinct head and
eart inducers within the Xenopus organizer region. Curr. Biol. 9,
00–809.
chneider, V.A., and Mercola, M. (2001). Wnt antagonism initiates
ardiogenesis in Xenopus laevis. Genes Dev. 15, 304–315.
okol, S.Y. (1993). Mesoderm formation in Xenopus ectodermal ex-
lants overexpressing Xwnt8: evidence for a cooperating signal
eaching the animal pole by gastrulation. Development 118, 1335–
342.
okol, S.Y. (1996). Analysis of Dishevelled signalling pathways dur-
ng Xenopus development. Curr. Biol. 6, 1456–1467.
XDbf4, a Wnt Inhibitor in Heart Development
715Sokol, S.Y. (1999). Wnt signaling and dorso-ventral axis specifica-
tion in vertebrates. Curr. Opin. Genet. Dev. 9, 405–410.
Sokol, S., Wong, G.G., and Melton, D.A. (1990). A mouse macro-
phage factor induces head structures and organizes a body axis in
Xenopus. Science 249, 561–564.
Stainier, D.Y. (2001). Zebrafish genetics and vertebrate heart forma-
tion. Nat. Rev. Genet. 2, 39–48.
Tonissen, K.F., Drysdale, T.A., Lints, T.J., Harvey, R.P., and Krieg,
P.A. (1994). XNkx-2.5, a Xenopus gene related to Nkx-2.5 and tin-
man: evidence for a conserved role in cardiac development. Dev.
Biol. 162, 325–328.
Turner, D.L., and Weintraub, H. (1994). Expression of achaete-scute
homolog 3 in Xenopus embryos converts ectodermal cells to a neu-
ral fate. Genes Dev. 8, 1434–1447.
Tutter, A.V., Fryer, C.J., and Jones, K.A. (2001). Chromatin-specific
regulation of LEF-1-beta-catenin transcription activation and inhi-
bition in vitro. Genes Dev. 15, 3342–3354.
Tzahor, E., and Lassar, A.B. (2001). Wnt signals from the neural tube
block ectopic cardiogenesis. Genes Dev. 15, 255–260.
van Es, J.H., Barker, N., and Clevers, H. (2003). You Wnt some, you
lose some: oncogenes in the Wnt signaling pathway. Curr. Opin.
Genet. Dev. 13, 28–33.
Vonica, A., Weng, W., Gumbiner, B.M., and Venuti, J.M. (2000). TCF
is the nuclear effector of the beta-catenin signal that patterns the
sea urchin animal-vegetal axis. Dev. Biol. 217, 230–243.
Walters, M.J., Wayman, G.A., and Christian, J.L. (2001). Bone mor-
phogenetic protein function is required for terminal differentiation
of the heart but not for early expression of cardiac marker genes.
Mech. Dev. 100, 263–273.
Waxman, J.S., Hocking, A.M., Stoick, C.L., and Moon, R.T. (2004).
Zebrafish Dapper1 and Dapper2 play distinct roles in Wnt-medi-
ated developmental processes. Development 131, 5909–5921.
Xanthos, J.B., Kofron, M., Tao, Q., Schaible, K., Wylie, C., and
Heasman, J. (2002). The roles of three signaling pathways in the
formation and function of the Spemann Organizer. Development
129, 4027–4043.
Yanow, S.K., Gold, D.A., Yoo, H.Y., and Dunphy, W.G. (2003). Xeno-
pus Drf1, a regulator of Cdc7, displays checkpoint-dependent ac-
cumulation on chromatin during an S-phase arrest. J. Biol. Chem.
278, 41083–41092.
Yelon, D. (2001). Cardiac patterning and morphogenesis in zebra-
fish. Dev. Dyn. 222, 552–563.
Yelon, D., Ticho, B., Halpern, M.E., Ruvinsky, I., Ho, R.K., Silver,
L.M., and Stainier, D.Y. (2000). The bHLH transcription factor Hand2
plays parallel roles in zebrafish heart and pectoral fin development.
Development 127, 2573–2582.
Zeng, L., Fagotto, F., Zhang, T., Hsu, W., Vasicek, T.J., Perry, W.L.,
3rd, Lee, J.J., Tilghman, S.M., Gumbiner, B.M., and Costantini, F.
(1997). The mouse Fused locus encodes Axin, an inhibitor of the
Wnt signaling pathway that regulates embryonic axis formation.
Cell 90, 181–192.
